SCHEMBL7654198

SCHEMBL7654198

COC(=O)c1cc(C(=O)O)ccc1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 2/20 0.44
MAPK1 P28482 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA7 P43166 1/20 0.44
TPMT P51580 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
PKM P14618 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
EPAS1 Q99814 1/20 0.41
NOTUM Q6P988 1/20 0.40
KDM4E B2RXH2 5/20 0.40
GAA P10253 3/20 0.40
MAPT P10636 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2314446 0.93 NOTUM (0.47) CA12CA1CA2CA7CA9
SCHEMBL1320505 0.90 AKR1C3 (0.42) EPAS1NOTUMKDM4EHSD17B10SMN1; SMN2
SCHEMBL14059001 0.89 NOTUM (0.47) HTTLMNACA12CA1CA2
SCHEMBL2317318 0.87 RAB9A (0.42) RAB9AHTTLMNAMAPK1CA12
SCHEMBL7665841 0.85 RAB9A (0.44) RAB9AHTTLMNAMAPK1CA12
SCHEMBL5937228 0.84 CYP46A1 (0.43) HTTLMNAMAPK1CA1CA2
SCHEMBL4634707 0.84 EPAS1 (0.47) LMNAMAPK1EPAS1KDM4ESMN1; SMN2
SCHEMBL14059584 0.84 NOTUM (0.42) LMNACA12CA1CA2CA7
SCHEMBL15826901 0.83 EPAS1 (0.49) HTTLMNAMAPK1EPAS1KDM4E
SCHEMBL17080255 0.83 KDM4E (0.48) HTTNPSR1EPAS1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed